• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于事件史分析的多状态模型。

Multi-state models for event history analysis.

作者信息

Andersen Per Kragh, Keiding Niels

机构信息

Department of Biostatistics, University of Copenhagen, Danish Epidemiology Science Centre, Copenhagen, Denmark.

出版信息

Stat Methods Med Res. 2002 Apr;11(2):91-115. doi: 10.1191/0962280202SM276ra.

DOI:10.1191/0962280202SM276ra
PMID:12040698
Abstract

An introduction to event history analysis via multi-state models in given. Examples include the two-state model for survival analysis, the competing risks and illness-death models, and models for bone marrow transplantation. Statistical model specification via transition intensities and likelihood inference is introduced. Consequences of observational patterns are discussed, and a real example concerning mortality and bleeding episodes in a liver cirrhosis trial is discussed.

摘要

本文介绍了通过多状态模型进行事件史分析。示例包括生存分析的两状态模型、竞争风险和疾病-死亡模型以及骨髓移植模型。介绍了通过转移强度和似然推断进行统计模型设定。讨论了观察模式的结果,并讨论了一个关于肝硬化试验中死亡率和出血事件的实际例子。

相似文献

1
Multi-state models for event history analysis.用于事件史分析的多状态模型。
Stat Methods Med Res. 2002 Apr;11(2):91-115. doi: 10.1191/0962280202SM276ra.
2
Multi-state models for bone marrow transplantation studies.用于骨髓移植研究的多状态模型
Stat Methods Med Res. 2002 Apr;11(2):117-39. doi: 10.1191/0962280202sm277ra.
3
Reduced rank proportional hazards model for competing risks.用于竞争风险的降秩比例风险模型。
Biostatistics. 2005 Jul;6(3):465-78. doi: 10.1093/biostatistics/kxi022. Epub 2005 Apr 14.
4
Inference for outcome probabilities in multi-state models.多状态模型中结局概率的推断。
Lifetime Data Anal. 2008 Dec;14(4):405-31. doi: 10.1007/s10985-008-9097-x. Epub 2008 Sep 13.
5
Competing risks as a multi-state model.作为多状态模型的竞争风险
Stat Methods Med Res. 2002 Apr;11(2):203-15. doi: 10.1191/0962280202sm281ra.
6
Inference for multi-state models from interval-censored data.基于区间删失数据的多状态模型推断
Stat Methods Med Res. 2002 Apr;11(2):167-82. doi: 10.1191/0962280202sm279ra.
7
Multi-state models and outcome prediction in bone marrow transplantation.骨髓移植中的多状态模型与结局预测
Stat Med. 2001 Jun 30;20(12):1871-85. doi: 10.1002/sim.810.
8
Estimation of covariate-dependent Markov transition probabilities from nested case-control data.从巢式病例对照数据估计协变量依赖的马尔可夫转移概率。
Stat Methods Med Res. 2002 Apr;11(2):183-202. doi: 10.1191/0962280202sm280ra.
9
The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models.mstate 包:用于非参数和半参数多状态和竞争风险模型的估计和预测。
Comput Methods Programs Biomed. 2010 Sep;99(3):261-74. doi: 10.1016/j.cmpb.2010.01.001. Epub 2010 Mar 15.
10
Asymptotic theory for the Cox semi-Markov illness-death model.考克斯半马尔可夫疾病死亡模型的渐近理论
Lifetime Data Anal. 2007 Mar;13(1):91-117. doi: 10.1007/s10985-006-9018-9.

引用本文的文献

1
Multiscale Modeling of Hospital Length of Stay for Successive SARS-CoV-2 Variants: A Multi-State Forecasting Framework.连续新冠病毒变异株的医院住院时长多尺度建模:多状态预测框架
Viruses. 2025 Jul 6;17(7):953. doi: 10.3390/v17070953.
2
Adherence to life's essential 8 and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study.坚持生命必需的8要素与心血管代谢多重疾病的进展轨迹:一项前瞻性队列研究
Nutr Metab (Lond). 2025 Jun 23;22(1):64. doi: 10.1186/s12986-025-00957-6.
3
The Cost-Effectiveness of Initiating Patients on Home Dialysis Compared with In-Centre Haemodialysis.
启动患者进行家庭透析与中心血液透析相比的成本效益
Appl Health Econ Health Policy. 2025 May 25. doi: 10.1007/s40258-025-00976-7.
4
Personalised Risk Modelling for Older Adult Cancer Survivors: Combining Wearable Data and Self-Reported Measures to Address Time-Varying Risks.老年癌症幸存者的个性化风险建模:结合可穿戴数据和自我报告措施以应对随时间变化的风险
Sensors (Basel). 2025 Mar 27;25(7):2097. doi: 10.3390/s25072097.
5
Chauhan Weighted Trajectory Analysis of Combined Efficacy and Safety Outcomes for Risk-Benefit Analysis.用于风险效益分析的联合疗效和安全性结果的乔汉加权轨迹分析
Pharm Stat. 2025 May-Jun;24(3):e70014. doi: 10.1002/pst.70014.
6
Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality.利用真实世界数据对2型糖尿病疾病进展进行建模:量化发病和死亡的竞争风险
CPT Pharmacometrics Syst Pharmacol. 2025 Mar;14(3):606-615. doi: 10.1002/psp4.13301. Epub 2025 Jan 17.
7
A Bayesian framework for causal analysis of recurrent events with timing misalignment.用于具有时间错位的复发事件因果分析的贝叶斯框架。
Biometrics. 2024 Oct 3;80(4). doi: 10.1093/biomtc/ujae145.
8
A Multistate Model Incorporating Relative Survival Extrapolation and Mixed Time Scales for Health Technology Assessment.一种用于卫生技术评估的、纳入相对生存外推法和混合时间尺度的多状态模型。
Pharmacoeconomics. 2025 Mar;43(3):297-310. doi: 10.1007/s40273-024-01457-w. Epub 2024 Nov 25.
9
Building a multistate model from electronic health records data for modeling long-term diabetes complications.利用电子健康记录数据构建多状态模型以模拟长期糖尿病并发症。
J Clin Transl Sci. 2024 Sep 23;8(1):e133. doi: 10.1017/cts.2024.583. eCollection 2024.
10
Tracing In-Hospital COVID-19 Outcomes: A Multistate Model Exploration (TRACE).追踪医院内新冠病毒感染的结果:多州模型探索(TRACE)
Life (Basel). 2024 Sep 21;14(9):1195. doi: 10.3390/life14091195.